← 產業報告目錄
Digital Therapeutics (DTx) For Mental Health Market Size, Share & Trends Analysis Report by Type (Biology Modifying Drugs, Gene Therapies, Cell Therapies), By Indication (Cancer, Musculoskeletal Disorders, Neurodegenerative Diseases, Rare Diseases, Hepatitis C, Others), By End User (Pharmaceutical Companies, Academic & Research Institutions, Others), Region And Segment Forecasts, 2025-2034
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-02-28頁數 180報告編號 INSIGHTACE-5567bc8e0b
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
Across the 2025 to 2034 projection horizon, the worldwide Digital Therapeutics (DTx) For Mental Health Market is projected to register a CAGR of 27.5%.
Digital Therapeutics (DTx) For Mental Health encompasses The use of digital technology, such as smartphone applications, software programs, and wearable, to deliver evidence-based interventions for the prevention, management, and treatment of various medica. The sector has gained traction as organizations seek innovative approaches to address evolving healthcare challenges.
Several factors contribute to this trajectory, including heightened interest in next-generation products, expanding applications across diverse end-use sectors, and supportive government initiatives.
The market landscape is structured across several key segments—spanning type, application, distribution channel, and region—each contributing uniquely to overall market expansion.
From a regional perspective, mature markets in North America and Europe continue to hold pronounced shares, while the Asia-Pacific region is gaining momentum through accelerated economic development and escalating investment in the sector.
Competition in this space is characterized by active product development, strategic collaborations, and geographic expansion among both global leaders and specialized niche players.
Through rigorous analysis of market trends, growth catalysts, restraints, and opportunities, this study offers valuable perspectives for companies, investors, and policymakers navigating this evolving landscape.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Digital Therapeutics (DTx) for Mental Health Market Snapshot
Chapter 4. Global Digital Therapeutics (DTx) for Mental Health Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis of Metaverse Industry
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. COVID-19 Impact on Metaverse Industry
Chapter 5. Market Segmentation 1: By Disease Indication Estimates & Trend Analysis
5.1. By Disease Indication & Market Share, 2024-2034
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Disease Indication:
5.2.1. Anxiety Disorder
5.2.2. Depression
5.2.3. Bipolar Disorder
5.2.4. Post-Traumatic Stress Disorder
5.2.5. Others
Chapter 6. Market Segmentation 2: By Application Estimates & Trend Analysis
6.1. By Disease Indication & Market Share, 2024-2034
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Application:
6.2.1. Preventive Care
6.2.2. Treatment/care Related
Chapter 7. Market Segmentation 3: By Sales Channel Estimates & Trend Analysis
7.1. By Disease Indication & Market Share, 2024-2034
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Sales Channel:
7.2.1.1. Payers
7.2.1.2. Pharmaceutical Companies
7.2.1.3. Providers
7.2.1.4. Caregivers
7.2.1.5. Patients
Chapter 8. Digital Therapeutics (DTx) for Mental Health Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Digital Therapeutics (DTx) for Mental Health Market revenue (US$ Million) estimates and forecasts By Disease Indication, 2021-2034
8.1.2. North America Digital Therapeutics (DTx) for Mental Health Market revenue (US$ Million) estimates and forecasts By Application, 2021-2034
8.1.3. North America Digital Therapeutics (DTx) for Mental Health Market revenue (US$ Million) estimates and forecasts By Sales Channel, 2021-2034
8.1.4. North America Digital Therapeutics (DTx) for Mental Health Market revenue (US$ Million) estimates and forecasts by country, 2021-2034
8.1.4.1. U.S.
8.1.4.2. Canada
8.2. Europe
8.2.1. Europe Digital Therapeutics (DTx) for Mental Health Market revenue (US$ Million) by Disease Indication, 2021-2034
8.2.2. Europe Digital Therapeutics (DTx) for Mental Health Market revenue (US$ Million) estimates and forecasts By Application, 2021-2034
8.2.3. Europe Digital Therapeutics (DTx) for Mental Health Market revenue (US$ Million) estimates and forecasts By Sales Channel, 2021-2034
8.2.4. Europe Digital Therapeutics (DTx) for Mental Health Market revenue (US$ Million) by country, 2021-2034
8.2.4.1. Germany
8.2.4.2. Poland
8.2.4.3. France
8.2.4.4. Italy
8.2.4.5. Spain
8.2.4.6. UK
8.2.4.7. Rest of Europe
8.3. Asia Pacific
8.3.1. Asia Pacific Digital Therapeutics (DTx) for Mental Health Market revenue (US$ Million) by Disease Indication, 2021-2034
8.3.2. Asia Pacific Digital Therapeutics (DTx) for Mental Health Market revenue (US$ Million) estimates and forecasts By Application, 2021-2034
8.3.3. Asia Pacific Digital Therapeutics (DTx) for Mental Health Market revenue (US$ Million) estimates and forecasts By Sales Channel, 2021-2034
8.3.4. Asia Pacific Digital Therapeutics (DTx) for Mental Health Market revenue (US$ Million) by country, 2021-2034
8.3.4.1. China
8.3.4.2. India
8.3.4.3. Japan
8.3.4.4. Australia
8.3.4.5. Rest of Asia Pacific
8.4. Latin America
8.4.1. Latin America Digital Therapeutics (DTx) for Mental Health Market revenue (US$ Million) by Disease Indication, 2021-2034
8.4.2. Latin America Digital Therapeutics (DTx) for Mental Health Market revenue (US$ Million) estimates and forecasts By Application, 2021-2034
8.4.3. Latin America Digital Therapeutics (DTx) for Mental Health Market revenue (US$ Million) estimates and forecasts By Sales Channel, 2021-2034
8.4.4. Latin America Digital Therapeutics (DTx) for Mental Health Market revenue (US$ Million) by country, (US$ Million) 2021-2034
8.4.4.1. Brazil
8.4.4.2. Rest of Latin America
8.5. Middle East & Africa
8.5.1. Middle East & Africa Digital Therapeutics (DTx) for Mental Health Market revenue (US$ Million) by Disease Indication, (US$ Million)
8.5.2. Middle East & Africa Digital Therapeutics (DTx) for Mental Health Market revenue (US$ Million) estimates and forecasts By Application, 2021-2034
8.5.3. Middle East & Africa Digital Therapeutics (DTx) for Mental Health Market revenue (US$ Million) estimates and forecasts By Sales Channel, 2021-2034
8.5.4. Middle East & Africa Digital Therapeutics (DTx) for Mental Health Market revenue (US$ Million) by country, (US$ Million) 2021-2034
8.5.4.1. South Africa
8.5.4.2. GCC Countries
8.5.4.3. Rest of MEA
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. Teladoc Health
9.2.2. WellDoc
9.2.3. Noom
9.2.4. Omada Health
9.2.5. Pear Therapeutics
9.2.6. COGNIFIT
9.2.7. Ginger
9.2.8. Propeller Health
9.2.9. 2morrow
9.2.10. Canary Health
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們